Voyager Therapeutics Inc (NASDAQ: VYGR) on Friday, plunged -3.42% from the previous trading day, before settling in for the closing price of $4.38. Within the past 52 weeks, VYGR’s price has moved between $4.00 and $10.66.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 126.57% over the last five years. The company achieved an average annual earnings per share of -131.11%. With a float of $44.87 million, this company’s outstanding shares have now reached $54.54 million.
The firm has a total of 162 workers. Let’s measure their productivity. In terms of profitability, gross margin is 77.42%, operating margin of 5.54%, and the pretax margin is 16.35%.
Voyager Therapeutics Inc (VYGR) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Voyager Therapeutics Inc is 17.44%, while institutional ownership is 63.49%. The most recent insider transaction that took place on Feb 11 ’25, was worth 24,088. In this transaction Chief Scientific Officer of this company sold 5,413 shares at a rate of $4.45, taking the stock ownership to the 81,023 shares. Before that another transaction happened on Feb 11 ’25, when Company’s COO & CBO sold 6,950 for $4.45, making the entire transaction worth $30,928. This insider now owns 102,291 shares in total.
Voyager Therapeutics Inc (VYGR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -131.11% per share during the next fiscal year.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Voyager Therapeutics Inc (VYGR) is currently performing well based on its current performance indicators. A quick ratio of 8.45 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.72, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Analysing the last 5-days average volume posted by the [Voyager Therapeutics Inc, VYGR], we can find that recorded value of 0.65 million was better than the volume posted last year of 0.38 million. As of the previous 9 days, the stock’s Stochastic %D was 19.28%. Additionally, its Average True Range was 0.35.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 5.35%, which indicates a significant decrease from 12.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 101.81% in the past 14 days, which was higher than the 83.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.64, while its 200-day Moving Average is $6.95. Now, the first resistance to watch is $4.49. This is followed by the second major resistance level at $4.74. The third major resistance level sits at $4.89. If the price goes on to break the first support level at $4.09, it is likely to go to the next support level at $3.94. Should the price break the second support level, the third support level stands at $3.69.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
Market capitalization of the company is 231.08 million based on 54,626K outstanding shares. Right now, sales total 250,010 K and income totals 132,330 K. The company made 24,630 K in profit during its latest quarter, and -9,040 K in sales during its previous quarter.
